Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Perry

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Neuro-Oncology Advances|January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trialAnnika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Journal of Neuro-Oncology|July 8, 2020
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patientsSeth A Climans, Alba A Brandes, J Gregory Cairncross, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi StudyWarren P Mason, Rebecca A Harrison, Sarah Lapointe, et al.
Neuro-Oncology|March 13, 2015
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE studyL Burt Nabors, Karen L Fink, Tom Mikkelsen, et al.
Nature Medicine|August 12, 2025
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final resultsZev A Wainberg, Colin D Weekes, Muhammad Furqan, et al.
Nature Medicine|January 9, 2024
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trialShubham Pant, Zev A Wainberg, Colin D Weekes, et al.
Nature Medicine|February 23, 2010
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeysDan H Barouch, Kara L O'Brien, Nathaniel L Simmons, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Neuro-Oncology Advances|January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trialAnnika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Journal of Neuro-Oncology|July 8, 2020
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patientsSeth A Climans, Alba A Brandes, J Gregory Cairncross, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi StudyWarren P Mason, Rebecca A Harrison, Sarah Lapointe, et al.
Neuro-Oncology|March 13, 2015
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE studyL Burt Nabors, Karen L Fink, Tom Mikkelsen, et al.
Nature Medicine|August 12, 2025
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final resultsZev A Wainberg, Colin D Weekes, Muhammad Furqan, et al.
Nature Medicine|January 9, 2024
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trialShubham Pant, Zev A Wainberg, Colin D Weekes, et al.
Nature Medicine|February 23, 2010
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeysDan H Barouch, Kara L O'Brien, Nathaniel L Simmons, et al.
Pageof 5